Impact of patient partnership in clinical trials
Impact of patient partnership in clinical trials: a pilot embedded cluster randomized trial
Adherence to medication and study protocol is a core issue for clinical trials’ success, affecting treatment efficacy estimates, study validity and costs. Patient engagement in research is attracting considerable interest as a potential strategy to improve trials’ conduct, with a recent meta-analysis showing a significant improvement in study participants’ recruitment. Economic models suggest large potential savings derived from patient engagement in research. However, solid RCT-level evidence of impact is lacking. Pilot trials of complex interventions like patient partnerships can help ensure that the proposed studies are feasible, acceptable and appropriate before full-scale implementation.
Assess the feasibility of conducting an embedded cluster randomized trial of patient partnership in clinical trials. Specific objectives are to:
- Assess the acceptance of the patient partnership intervention at the study and patient levels;
- Determine measures of outcomes used in the definitive trial;
- Estimate effect size and intra-cluster correlation coefficient for the medication and protocol adherence outcomes (for definitive trial sample size calculation); and
- Estimate cost of the partnership intervention (for trial budget calculation).
Pilot step-wedge cluster randomized trial, embedded in a host clinical trial of precision medicine anticoagulation treatment for prevention of cognitive decline in people with atrial fibrillation (BRAIN-AF).
The project is part of the Pharmacogenomics and Biomarkers substudy BRAIN-AF-PGx of the Double-Blinded Randomized trial of Anticoagulation to prevent Ischemic stroke and Neurocognitive Impairment in Atrial Fibrillation (BRAIN-AF) led by the Montreal Heart Institute.
In collaboration with: